QIAGEN
NEWS
Luminostics, Inc., to receive $10,000 cash prize and recognition from the rapid point-of-care diagnostics industry
DCN Dx and Qiagen Lake Constance are pleased to announce five finalists for its second Rapid Testing Innovation Award.
Companies strengthen their leadership teams and boards of directors with these appointments.
The collaboration will focus on Inovio’s VGX-3100, which stimulates a specific immune response to HPV-16 and HPV-18, targeting the infection and causing destruction of precancerous cells.
DCN Dx and QIAGEN Lake Constance announced today that Rapid Pathogen Screening, Inc. (RPS) was the winner of the first $10,000 Innovation Award at the Advanced Lateral Flow Course.
Qiagen’s investment will be an expansion of its current operations in that northern England city.
JOBS
IN THE PRESS